sglt2 and glp 1 together Renal outcomes of inhibitors GLP1 agonists in clinical practice Frontiers | Effects of SGLT2

GLP-1 Market in Asia-Pacific, till 2035 18.2.4

It is supplied strictly for scientific, analytical, and in-vitro laboratory research use only

GLP-1 Drugs present a promising avenue for intervention: Overlapping risk factors: Given the shared risk factors between diabetes and liver disease, the diabetic drug Ozempic is projected to become the second-highest-grossing treatment for NAFLD and NASH by 2028

It's not a willpower issue

Stewart, JM, et al

for Wegovy, follow current SmPC guidance on reassessment) [6] Tolerability and side effects Blood pressure and metabolic parameters Psychological wellbeing and eating behaviours Important safety considerations include: GLP-1 medications are not recommended during pregnancy or breastfeeding